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Abstract
Background: The type-1 cytokine pathway plays a pivotal role in immunity against intracellular bacterial pathogens such as
Salmonellae and Mycobacteria. Bacterial stimulation of pattern recognition receptors on monocytes, macrophages and
dendritic cells initiates this pathway, and results in the production of cytokines that activate lymphocytes to produce
interferon (IFN)-c. Interleukin (IL)-12 and IL-23 are thought to be the key cytokines required for initiating a type-1 cytokine
immune response to Mycobacteria and Salmonellae. The relative contribution of IL-23 and IL-12 to this process is uncertain.
Methodology/Principal Findings: We show that various TLR agonists induce the production of IL-23 but not IL-12 in freshly
isolated human monocytes and cultured human macrophages. In addition, type 1 pro-inflammatory macrophages (MQ1)
differentiated in the presence of GM-CSF and infected with live Salmonella produce IL-23, IL-1b and IL-18, but not IL-12.
SupernatantsofSalmonella-infected MQ1containedmoreIL-18andIL-1bascomparedwithsupernatantsofMQ1s t i m u l at e dwi th
isolated TLR agonists, and induced IFN-c production in human CD56
+ cells in an IL-23 and IL-1b-dependent but IL-12-
independent manner. In addition, IL-23 together with IL-18 or IL-1b led to the production of GM-CSF in CD56
+ cells. Both IFN-c
and GM-CSF enhanced IL-23 production by monocytes in response to TLR agonists, as well as induced IL-12 production.
Conclusions/Significance: The findings implicate a positive feedback loop in which IL-23 can enhance its release via
induction of IFN-c and GM-CSF. The IL-23 induced cytokines allow for the subsequent production of IL-12 and amplify the
IFN-c production in the type-1 cytokine pathway.
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Introduction
Immunity against intracellular bacterial pathogens such as
Salmonellae and Mycobacteria depends on the type-1 cytokine
pathway [1]. This pathway is initiated by bacterial stimulation of
pattern recognition receptors on monocytes and macrophages,
resulting in the production of cytokines that activate lymphocytes
and induce IFN-c production. The IFN-c in turn activates
monocytes and macrophages, to enhance bactericidal effector
mechanisms and to further pro-inflammatory cytokine production.
Thus, the type-1 cytokine pathway critically depends on the cross-
talk between monocytes/macrophages and lymphocytes. Abdi
et al. state that IL-12p70 cannot be the primary trigger that
initiates Th1 T-cell responses, as it is not produced in response to
bacterial stimulation when costimulation in the form of activated
T cells or IFN-c are absent [2]. In addition, in whole blood assays
with blood obtained from patients with complete IFN-cR
deficiency, no IL-12p70 production can be detected in response
to M. bovis BCG infection in vitro [3]. How the type-1 pathway is
initiated, therefore, has remained uncertain.
Interleukin-23 (IL-23) is a cytokine which is produced early in
the immune response [4]. Monocytes as well as type 1
macrophages (MQ1) produce IL-23 in response to the binding of
pathogens and pathogen-associated molecular patterns (PAMPs),
such as lipopolysaccharide (LPS), to Toll-like receptors (TLRs)
[5,6]. In contrast to IL-23, for the production of IL-12 in response
to PAMPs an additional stimulus such as IFN-c is required [5]. IL-
23 is known to induce IFN-c production in naı ¨ve T cells, in
memory T cells [7] and in NK-like T cells [8], thereby potentially
providing the necessary, additional stimulus to induce IL-12
production. Next, IL-12 and IL-18 enhance IFN-c production in
NK, NK-like T cells and Th1 cells by binding to their respective
receptors [9]. Though IFN-c is not required for the induction of
IL-23, the precise role of IFN-c in the regulation of IL-23 is not
well established.
Granulocyte-Macrophage Colony Stimulating Factor (GM-
CSF) is a cytokine produced by NK cells and T cells in response
to a variety of stimuli, for instance IL-15 and IL-18 [10]. GM-CSF
activates monocytes and enhances their bactericidal activity
[11–13]. Moreover, monocytes pre-stimulated with GM-CSF
secrete increased quantities of tumor necrosis factor (TNF) and
IL-1b when stimulated with LPS [14,15]. Furthermore, GM-CSF
induces differentiation of human monocytes into MQ1, a
macrophage type that is capable of producing IL-23 [5].
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1b, IL-18, GM-CSF and IFN-c in the crosstalk between NK/NK-
like T cells and monocytes/macrophages in the early activation of
the type-1 cytokine pathway. To this end we determined which
TLR agonists induce IL-23 production in human monocytes and
macrophages and assessed the roles of GM-CSF and IFN-c in the
regulation of IL-23 production by human monocytes in response
to TLR agonists. Furthermore, we explored the role of Salmonella-
induced IL-23, IL-1b and IL-18 in the induction of IFN-c in
primary human NK/NK-like T cells, and tested the capacities of
IL-23, IL-1b and IL-18 to induce GM-CSF and IFN-c in human
NK and NK-like T cells.
Materials and Methods
Cells and Culture Conditions
Human CD14
+ cells and CD56
+ cells were isolated from buffy
coats from healthy donors (Sanquin) by Ficoll-Amidotrizoate
density gradient centrifugation and subsequent selection with anti-
CD14 MACS beads or anti-CD56 MACS beads (Miltenyi
Biotech).
CD14
+ cells were cultured in RPMI-1630 medium, supple-
mented with 20 mM GlutaMAX (Gibco/Invitrogen), 10% FCS,
100 U/ml Penicillin, 100 mg/ml Streptomycin (Gibco/Invitro-
gen). CD56
+ cells were cultured in Iscove’s modified Dulbecco’s
medium (IMDM, Bio-Whittaker) supplemented with 20 mM
GlutaMAX, 10% FCS, 100 U/ml Penicillin, 100 mg/ml Strepto-
mycin. To generate MQ1, CD14
+ cells were cultured for 6 days in
RPMI 1640 with 10% FCS and 5 ng/ml GM-CSF (Biosource).
Cytokine Induction and Measurement
To determine cytokine production by monocytes, CD14
+ beads
isolated cells were seeded in a 96-well plate at 1?10
5 cells per well
and cultured for 24 h in the presence or absence of the following
TLR agonists: 100 ng/ml S. minnesota LPS (Sigma), 200 ng/ml
recombinant flagellin (tlrl-flic, InvivoGen), 1 mg/ml Pam3CSK4
(tlrl-pms, InvivoGen), 100 mg/ml Zymosan A (Sigma), 1 mg/ml
CL075 (tlrl-c75, InvivoGen) or 1 mg/ml CL087 (tlrl-c87, Invivo-
Gen) in a final volume of 200 ml. Supernatants were taken and IL-
23 (eBioscience), IL-1b (Biosource) IL-18 (MBL) and IL-12p70
(Sanquin) concentrations were determined by ELISA. For exper-
iments with MQ1, cells were harvested with trypsin-EDTA, washed
with PBS and seeded at 3.3?10
5 per well in 24-well or 1?10
6 in 12-
well culture plates (Corning Life Sciences) and allowed to adhere.
Subsequently MQ1 were stimulated with TLR agonists, infected
with group B Salmonella at a 10:1 multiplicity of infection as
described below, or left unstimulated. Twenty-four hours after
stimulation, supernatants were collected and cytokine production
wasdeterminedbyELISA.To test the effect ofGM-CSFand IFN-c
pre-stimulation, 1?10
5 CD14
+ monocytes were cultured for
16 hours with 50–5000 pg/ml GM-CSF, 50–5000 pg/ml IFN-c
(Biosource) or left unstimulated. Subsequently cells were stimulated
with 100 ng/nl LPS plus 1 mg/ml CL075 for 24 hours, or left
unstimulated. After stimulation cell free supernatants were collected
and IL-23 production was determined by ELISA (eBioscience).
Supernatant Transfer Experiments
To generate supernatants from Salmonella stimulated MQ1,
1?10
6 cells were seeded in a 12-well plate and infected with group
B Salmonella at a 10:1 multiplicity of infection. To promote the
uptake of bacteria, the bacteria were spun onto the macrophages
by centrifugation at 3006g for 5 min and the cells were allowed to
internalize the bacteria for 30 min at 37uC, 5% CO2. Cells were
washed 3 times with PBS after which medium containing 50 mg/
ml gentamicin (Sigma) was added to kill extracellular Salmonellae.
After 30 minutes, medium was replaced with 2 ml fresh medium
containing 10 mg/ml gentamicin. Twenty-four hours after infec-
tion, cell free supernatants were collected and used to stimulate
anti-CD56 beads isolated cells. Overnight rested CD56
+ cells were
seeded 1?10
5 cells per well in a 96-well plate and stimulated for
48 hr with 100 ml of conditioned MQ1 medium, with or without
100 ng/ml IL-18 (MBL), in a final volume of 200 ml. After
48 hours of culture, cell free supernatants were collected and IFN-
c production was measured by cytokine specific ELISA (Bio-
source). For cytokine neutralization assays, macrophage superna-
tants were pre-incubated with 10 mg/ml anti-IL-12p40 (C8.6,
eBiosciences) or 10 mg/ml anti-IL-18 (MBL) or 5 mg/ml anti IL-
1b (BD Biosciences) for 30 minutes at 37uC.
To generate supernatants of CD56
+ cells, 1?10
6 cells were
stimulated with 10 ng/ml IL-23 plus 10 ng/ml IL-1b, or left
unstimulated, for 24 hours. Cell free supernatants were collected
and used to stimulate CD14
+ monocytes. CD14
+ cells were seeded
1?10
5 cells per well in a 96-well plate and stimulated for 24 hr with
100 ng/ml LPS, in combination with 100 ml supernatant of
CD56
+ cells, 2.5 ng/ml IFN-c (Biosource) or medium in a final
volume of 200 ml. To neutralize IFN-c, supernatants from
stimulated CD56
+ cells were pre-incubated with 2 mg/ml anti-
IFN-c (Genzyme) for 30 minutes at 37uC. Supernatants were
collected and IL-12p70 was measured by cytokine specific ELISA
(BD Bioscience).
IFN-c and GM-CSF Production
To determine GM-CSF and IFN-c production in NK and NK-
like T cells, overnight-rested CD56
+ beads-isolated cells were
seeded 1?10
5 cells per well in a 96-well plate and stimulated for
24 hr with various concentrations of IL-23, alone or in
combination with various concentrations of IL-18 (MBL) or IL-
1b (Biosource) in a final volume of 200 ml. Concentrations of IFN-
c and GM-CSF in the cell free supernatants were determined by
cytokine-specific ELISA (Biosource).
For intracellular staining of IFN-c, CD56
+ beads-isolated cells
were seeded 10
5 cells/well in 96-well plates and stimulated with
IL-23 (R&D Systems), IL-18 (MBL), IL-1b (Biosource) or a
combination of these cytokines for 48 hours. The last 5 hours of
stimulation BD GolgiPlug (BD PharMingen) was added (final
concentration 1:1000). Cells were fixed in 4% paraformaldehyde
(Sigma) and permeabilised in 90% methanol. Cells were stained
with Alexa 647-labeled anti-human IFN-c in combination with
PE-labeled anti-human CD56 and FITC-labeled anti-human CD3
(BD PharMingen).
Results
Monocytes and MQ1 Produce IL-23, but Not IL-12, in
Response to Various TLR Agonists
LPS is known to induce IL-23, but not IL-12, production in
MQ1 [5]. To determine whether various TLR agonists are capable
of inducing IL-23 or IL-12 production in monocytes and MQ1, we
first tested these capacities in freshly isolated human monocytes.
Unstimulated monocytes did not produce IL-23, whereas
Zymosan A (agonist for TLR2/6) induced minimal IL-23
production, LPS (TLR4) and CL075 (TLR8/7) each induced
small amounts of IL-23, while LPS and CL075 synergized in the
induction of IL-23 production in monocytes (Fig. 1A). IL-23
production was also observed in response to LPS plus flagellin
(TLR5) but the amount released was similar to that induced by
LPS alone. Of note, the amounts of IL-23 produced by CD14
+
monocytes varied somewhat between different donors, the relative
IL-23 Positive Feedback Loop
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similar (data not shown). In none of the supernatants IL-12p70
was detected, given a detection limit of the IL-12p70 ELISA of
3 pg/ml (data not shown).
Next, we compared the amount of IL-23 and IL-12 produced
by monocytes to those by cultured MQ1. Upon incubation with
each of the TLR agonists MQ1 produced IL-23 (Fig. 1B). LPS
synergized with both CL075 and flagellin in the induction of IL-
23. As compared with freshly isolated monocytes at identical cell
number and incubation conditions, MQ1 produced markedly
more IL-23 in response to the TLR agonists. Again, no IL-12p70
production was detected in response to any of the stimuli (data not
shown). To verify that the Mw1 used in these experiments are
capable of producing IL-12p70 they were stimulated with LPS in
combination with IFN-c. Large amounts of IL-12p70 were
detected in the supernatants (data not shown).
Infection of MQ1 with Live Salmonella Induces IL-23, but
Not IL-12, Production
To determine whether not only PAMPs such as the TLR
agonists, but also live pathogens induce IL-23 rather than IL-12
production in MQ1, we infected cultured MQ1 with live Salmonella
and assessed cytokine release in the culture supernatants. MQ1
exposed to and containing ingested Salmonellae produced IL-23
whereas MQ1 left unstimulated did not (Fig. 1C). Of note,
Salmonella infected MQ1 produced markedly more IL-23 as
compared with MQ1 stimulated with large amounts of LPS
(Fig. 1C). Similar to stimulation with TLR agonists, we did not
detect any IL-12p70 in the supernatants of infected MQ1 (data not
shown). Moreover, in a related project, micro-array analysis of
MQ1 infected with live Salmonella for 1, 2, 4, 8 and 24 hours
revealed that infection did not induce IL12A (IL-12p35) transcrip-
tion, whereas IL12B (IL-12p40) and IL23A (IL-23p19) transcrip-
Figure 1. TLR stimuli and Salmonella infection induce IL-23 production in human monocytes and MQ1. 1 ?10
5 overnight rested anti-
CD14 beads-isolated monocytes (A) or 5 ?10
4 MQ1 (B) were stimulated with 100 ng/ml LPS, 200 ng/ml flagellin (flag), 1 mg/ml Pam3CSK4,
100 mg/ml Zymosan A, 1 mg/ml CL075, 1 mg/ml CL087, 100 ng/ml LPS plus 200 ng/ml flagellin, LPS 100 ng/ml plus 1 mg/ml CL075 for 24 hours,
or left unstimulated. (C) MQ1 were infected with live Salmonella with a multiplicity of infection (MOI) of 10, left uninfected or were stimulated
with 100 ng/ml LPS. Supernatants were collected after 24 hours and IL-23 protein production was assessed by ELISA. Data are means6standard
deviation (SD) of triplicates in one representative experiment of five (A and B) or means of duplicates in one representative experiment of three
(C).
doi:10.1371/journal.pone.0008396.g001
IL-23 Positive Feedback Loop
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Wetering, unpublished data).
TLR Stimuli and Infection with Live Salmonella Induce IL-
18 and IL-1b Production
We have shown previously that for IL-23 to induce IFN-c
production in NK-like T cells, an additional stimulus such as IL-18
is required [8]. Similar to IL-18, IL-1b can costimulate for IFN-c
production [16,17]. To determine whether the production of IL-
23 occurs in concert with that of IL-18 or IL-1b, we assayed the
production of these cytokines by MQ1 in response to LPS or
infection with Salmonella. Unstimulated cells produced minimal IL-
18, but no IL-1b. Although IL-18 and IL-1b production in
response to LPS and infection varied markedly between donors;
MQ1 of all donors produced both IL-18 and IL-1b in response to
these stimulations (Fig. 2A and B). Salmonella-infected MQ1
produced markedly more IL-18 and IL-1b as compared with
cells stimulated with LPS (Fig. 2A and B).
IL-23 and IL-1b Synergize in the Induction of IFN-c in
CD56
+ Cells
Infection of MQ1 with live Salmonella resulted in the
production of IL-23, IL-18 and IL-1b. IL-23 is reported to
induce IFN-c production in NK, NK-like T cells and in T cells,
in synergy with IL-18 [7,8,18]. As mentioned before, IL-1b is
known to enhance IL-12 induced IFN-c production [16,17].
Therefore, we tested whether perhaps IL-23 in combination with
IL-1b could also induce IFN-c production in CD56
+ (NK and
NK-like T) cells. Each cytokine alone was not able to induce IFN-
c production (Fig. 3). However, when IL-23 and IL-1b were
combined, they synergized in inducing IFN-c production (Fig. 3).
Isolated CD56
+ cells consist of CD56
+/CD3
2 NK cells and
CD56
+/CD3
+ NK-like T cells. We next determined which of
these two populations were responsible for the observed IFN-c
production by IL-23 plus IL-1b stimulated CD56
+ cells. Because
sorting CD3
+ cells with an anti-CD3 antibody induces undesired
activation of the cells, we used intracellular staining for IFN-c in
combination with CD3/CD56 labeling. We arbitrarily designated
a population positive for IFN-c when more than 1% of the cells
stained IFN-c positive. CD56
+ cells obtained from eight donors
were stimulated with IL-23, IL-1b, IL-18, IL-23 plus IL-1b,I L -
23 plus IL-18, or left unstimulated for 48 hours. No significant
IFN-c production was observed in unstimulated cells or cells
stimulated with either IL-23, IL-1b or IL-18 (Fig. 4). Surprisingly,
the cells producing IFN-c in response to IL-23 plus IL-1b or IL-
23 plus IL-18 varied between donors. In response to IL-23 plus
IL-1b in half of the donors IFN-c production was observed in
both CD56
+/CD3
2 NK cells and CD56
+/CD3
+ NK-like T cells,
whereas in the other half IFN-c production was only observed in
CD56
+/CD3
2 NK-like T cells (Table 1). In response to IL-23
plus IL-18 IFN-c production was observed in both populations in
seven donors, while in one donor only CD56
+CD3
2 cells
produced IFN-c (Table 1). On average, significant IFN-c
production was observed in response to IL-23 plus IL-1b or IL-
18 in NK cells, while in NK-like T cells only IL-23 plus IL-1b
resulted in significant IFN-c production (Fig. 4).
Since IL-23 in combination with IL-1b is known to promote the
production of IL-17 in memory T cells [19], we also analyzed IL-
17 production by CD56
+ cells in response to IL-23 and IL-1b.
However, in none of the supernatants IL-17 was detected (data not
shown).
Supernatants of Salmonella Infected MQ1 Induce IFN-c
Production in Primary CD56
+ Cells
So far we found that IL-23, IL-18 and IL-1b, but not IL-12p70,
are present in supernatants of Salmonella infected MQ1. We showed
that IL-23 can induce IFN-c production in CD56
+ when IL-1b is
present. Previously, we have shown that CD56
+ cells produce IFN-
c when stimulated with IL-23 plus IL-18, in the absence of IL-12
[8]. Based on these data we expected that supernatants from
Salmonella infected MQ1 would be able to induce IFN-c production
in CD56
+ cells. Supernatants of Salmonella infected MQ1 were
indeed able to induce IFN-c production in primary CD56
+ cells
Figure 2. Salmonella infection induces IL-18 and IL-1b produc-
tion in MQ1. 3.3 ?10
5 MQ1 of five different donors were left
unstimulated, stimulated with LPS or infected with Salmonella with a
MOI of 10. Supernatants were collected after 24 hours and IL-18 (A) and
IL-1b (B) production was measured by ELISA. Each dot represents one
donor. The mean is indicated by a horizontal line. A paired two-tailed
student’s t-test was used for statistical analysis. n.d.=not detected.
doi:10.1371/journal.pone.0008396.g002
Figure 3. IL-23, in combination with IL-1b, induces IFN-c
production in primary human CD56
+ cells. Anti-CD56 MACS bead
isolated cells were rested overnight and then left unstimulated or
stimulated with indicated concentrations of IL-23 in combination with
various concentrations of IL-1b. Supernatants were collected 24 hours
after stimulation and IFN-c concentration was measured by ELISA. IL-23
and IL-1b synergize in the induction of IFN-c. One representative
experiment of three is shown.
doi:10.1371/journal.pone.0008396.g003
IL-23 Positive Feedback Loop
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their ability to induce IFN-c production (data not shown).
Since IL-18 is induced in small amounts only, even after
infection by Salmonella, we determined whether IL-18 was a
limiting factor in the induction of IFN-c in CD56
+ cells by
supernatants of MQ1 infected with Salmonella. The addition of
recombinant IL-18 to the supernatants increased the IFN-c
production by these CD56
+ cells (Fig. 5A).
IL-23 and IL-1b, but Not IL-18, in Supernatants Are Critical
for the Induction of IFN-c Production in CD56
+ Cells
To verify the role of IL-23 in the induction of IFN-c by
supernatants of Salmonella infected MQ1, we neutralized IL-23
using an antibody binding the p40 subunit of IL-23. (Note that
although the p40 antibody can also neutralize IL-12, we have
shown above that no IL-12 was present in these supernatants).
When IL-23 was thus neutralized, IFN-c production was
effectively abrogated (Fig. 5B), even when exogenous IL-18 was
added (data not shown).
Similarly, to specify the role of IL-18 and IL-1b in the
supernatants of Salmonella-infected MQ1 in the induction of IFN-c
production, we used a specific antibody to neutralize these
interleukins. Pilot experiments had confirmed that the IL-18
antibody could neutralize a large amount of recombinant IL-18
(4 ng/ml) effectively (data not shown). Although exogenous IL-18
enhanced the MQ1 supernatant-induced IFN-c production by
CD56
+ cells, neutralization of IL-18 in this supernatant did not
affect the production of IFN-c significantly (Fig. 5B), suggesting
IL-18 is not crucial in this respect. In contrast, neutralization of IL-
1b reduced the capacity of the supernatants to induce IFN-c
production significantly (Fig. 5B).
IL-23, in Synergy with IL-18 or IL-1b, Induces GM-CSF
Production in CD56
+ NK/NK-Like T Cells
IL-18 is known to induce GM-CSF production in NK cells in
combination with various cytokines [10]. To determine whether IL-
18 or IL-1b, combined with IL-23 can induce GM-CSF production
in human CD56
+ NK/NK-like T cells, these cells were stimulated
with IL-18, IL-1b or IL-23 and combinations of these cytokines, or
leftunstimulatedfor24 hours.Unstimulatedcellsandcellsstimulated
with IL-23 alone did not produceany GM-CSF (Fig. 6A). In contrast,
IL-18 alone induced a small amount of GM-CSF, when high
concentrations were used. In combination with IL-23 on the other
hand, IL-18 induced considerable amounts of GM-CSF in CD56
+
cells (Fig. 6A). CD56
+ cells stimulated with high concentrations of IL-
1b produced GM-CSF, whereas cells stimulated with lower
concentrations of IL-1b did not. IL-23 synergized with IL-1b in
inducing GM-CSF (Fig. 6B). For both IL-18 and IL-1b,s t r o n g e s t
synergy was observed at highest concentrations.
GM-CSF and IFN-c Prime Monocytes for Enhanced IL-23
Production
MQ1 generated by culturing CD14
+ monocytes for six days in
the presence of GM-CSF are strong producers of IL-23 compared
with freshly isolated CD14
+ monocytes ([5] and above). To
investigate whether GM-CSF or IFN-c (known to enhance the
expression of the IL-23 subunit IL-12p40 [20]) could prime
monocytes directly for enhanced IL-23 production in response to
stimulation with heat killed Salmonella, we pre-stimulated CD14
+
Figure 4. IL-23 in combination with IL-1b or IL-18 induces IFN-c
production in both CD56
+/CD3
2 NK cells and CD56
+/CD3
+ NK-
like T cells. Anti-CD56 MACS bead isolated cells were rested overnight
and then left unstimulated or stimulated with 10 ng/ml IL-1b, 100 ng/
ml IL-18, 10 ng/ml IL-23, 10 ng/ml IL-1b plus 10 ng/ml IL-23 or 100 ng/
ml IL-18 plus 10 ng/ml IL-23, for 48 hours. Cells were fixed,
permeabilised and labeled with anti-human CD3-PE, anti-human
CD56-FITC and anti-human IFN-c-Alexa 647. Unstimulated cells and
cells stimulated with a single cytokine do not produce significant
amounts of IFN-c. CD3
2 NK cells stimulated with IL-1b or IL-18 in
combination with IL-23 induce significant IFN-c production, while in
CD3
+ NK-like Tcells only IL-23 plus IL-18 induces significant IFN-c
production. Data are means6SD of experiments with cells obtained
from 8 donors. Two-tailed paired t-tests were performed of stimulated
cells versus unstimulated cells. * indicates a p-value,0.05.
doi:10.1371/journal.pone.0008396.g004
Table 1. Percentages of IFN-c producing CD56
+ cells after
stimulation with cytokines.
Stimulation
- IL-23
Donor Fraction - IL-1b IL-18 - IL-1b IL-18
1 CD3
2 0,2 0,8 0,2 0,4 3,0 6,7
CD3
+ 0,0 0,1 0,0 0,1 0,2 0,7
2 CD3
2 0,1 0,3 0,2 0,3 1,9 4,4
CD3
+ 0,1 0,1 0,1 0,2 0,6 4,8
3 CD3
2 0,1 0,1 0,0 0,2 1,5 7,5
CD3
+ 0,1 1,2 0,0 0,1 11,6 35,9
4 CD3
2 0,1 0,3 0,0 0,1 3,2 53,4
CD3
+ 0,0 0,4 0,0 0,0 1,2 84,1
5 CD3
2 0,2 6,1 3,9 2,8 9,7 15,8
CD3
+ 0,1 0,6 3,9 0,3 2,3 19,5
6 CD3
2 0,0 0,1 0,1 0,1 1,2 3,4
CD3
+ 0,1 0,0 0,0 0,0 0,5 10,0
7 CD3
2 0,1 0,1 0,2 0,5 2,4 9,0
CD3
+ 0,1 0,2 0,0 0,1 1,0 7,5
8 CD3
2 0,1 0,3 0,0 1,0 4,7 17,8
CD3
+ 0,0 0,0 0,0 0,0 0,1 2,7
Percentages of IFN-c producing CD56
+/CD3
2 NK cells and CD56
+/CD3
+ NK-like
T cells for each of eight donors after stimulation of CD56
+ cells with the
indicated cytokines for 48 h.
doi:10.1371/journal.pone.0008396.t001
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production. Stimulation of monocytes with GM-CSF or IFN-c
alone did not induce IL-23 production (Fig. 7A and 7B). However,
sixteen hours of pre-stimulation of monocytes with as little as
50 pg/ml GM-CSF enhanced IL-23 production in response to
heat killed Salmonella (Fig. 7A), with a dose dependent priming
effect (Fig. 7A). Similar to GM-CSF, pre-stimulation of monocytes
with IFN-c also enhanced IL-23 production in response to heat
killed Salmonella, again in a dose dependent manner (Fig. 7B).
IL-23 Plus IL-1b Stimulated CD56
+ Cells Prime Monocytes
for IL-12p70 Production
To produce IL-12p70 in response to LPS, IFN-c is needed as an
extra stimulus. CD56
+ cells produce IFN-c in response to IL-23
plus IL-1b, therefore we wanted to know whether supernatants of
IL-23/IL-1b stimulated CD56
+ cells could prime monocytes for
IL-12p70 production in response to LPS. Monocytes were
stimulated with LPS, plus or minus supernatants of IL23/IL-1b
stimulated CD56
+ cells or, as a positive control, IFN-c. Monocytes
stimulated with LPS alone did not produce IL-12p70, whereas
cells stimulated with LPS in combination with IFN-c or
supernatants of IL-23 plus IL-1b stimulated CD56
+ cells both
produced IL-12p70 (Fig. 8A). To assess the role of IFN-c present
in the supernatants of IL-23 plus IL-1b stimulated CD56
+ cells in
the priming effect on IL-12p70 production by monocytes, we used
an IFN-c neutralizing antibody. Neutralization of IFN-c greatly
diminished the priming effect of these supernatants on LPS
induced IL-12p70 production by monocytes (Fig. 8B). Of note, IL-
23 plus IL-1b did not directly prime monocytes to produce IL-
12p70 in response to LPS (data not shown).
Figure 5. Supernatants of Salmonella-infected MQ1 induce IFN-c production in primary human CD56
+ cells. (A) IFN-c production by
CD56
+ NK/NK-like T cells from two donors. Cells were cultured for 48 hours in the presence of supernatants obtained from uninfected or Salmonella
infected MQ1 (from two donors) with or without additional exogenous recombinant IL-18. As a control, medium only was used. Data are means6SD
of triplicates in one representative experiment of three. (B) IFN-c production in CD56
+ cells induced by supernatants of Salmonella-infected MQ1i s
blocked by neutralizing IL-12p40 or IL-1b, but not by neutralizing IL-18. CD56
+ NK/NK-like T cells were cultured for 48 hours in the presence or
absence of supernatant obtained from MQ1 cells infected with Salmonella, in the presence or absence of an IL-12p40, IL-18 or IL-1b neutralizing
antibody. IFN-c concentration was determined by ELISA. IFN-c production induced by supernatants of Salmonella infected MQ1 is set at 100%. A
paired two-tailed student’s t-test was used for statistical analysis. Data are means6SEM of experiments with cells obtained from 10 different donors.
doi:10.1371/journal.pone.0008396.g005
Figure 6. IL-23 in synergy with IL-18 or IL-1b induces GM-CSF in CD56
+ cells. 1?10
5 anti-CD56 beads isolated cells were rested for 24 hours
and then left unstimulated or stimulated with indicated concentrations of IL-23 in combination with various concentrations of IL-18 (A) or IL-1b (B). IL-
18 or a combination of these cytokines. Supernatants were collected 24 hours after stimulation and GM-CSF protein production was measured by
ELISA. One representative experiment of three is shown.
doi:10.1371/journal.pone.0008396.g006
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In this study we demonstrate that human monocytes and
cultured pro-inflammatory macrophages (i.e., MQ1) both produce
IL-23, IL-18 and IL-1b in response to various TLR agonists,
during co-incubation and upon ingestion of live Salmonella.
Subsequently, in response to IL-23 in combination with IL-18 or
IL-1b, CD56
+ cells produce IFN-c and GM-CSF. These cytokines
in turn enhance IL-23 production by monocytes and macrophages
in response to TLR agonists, implying a positive feedback loop.
Furthermore, supernatants of Salmonella infected MQ1 induce IFN-
c production in CD56
+ cells and this induction of IFN-c was
critically dependent on IL-23 and IL-1b. Finally, supernatants
from IL-23 plus IL-1b stimulated CD56
+ cells allowed monocytes
to produce IL-12p70 in response to LPS.
The assumption of an IL-23 positive feedback loop is based on
the following observations: (1) We demonstrated that monocytes as
well as MQ1 are able to produce IL-23 in response to various TLR
agonists. In addition, monocytes and MQ1 produced small
amounts of IL-18 and IL-1b in response to individual TLR
agonists, while cells infected with live Salmonella produced large
amounts of IL-18, IL-1b and IL-23. In line, Verreck et al. showed
that MQ1 produce IL-23 and IL-1b in response to LPS or
mycobacterial sonicate [21]. (2) Guia et al. reported that in the
presence of macrophages infected with Salmonella in vitro, CD56
+
NK-like T cells, but not CD56
2 T cells produce IFN-c in absence
of TCR stimulation [22]. Here we show that IL-23 and IL-1b in
these supernatants of Salmonella infected MQ1 were critical
components for the induction of IFN-c production in the
CD56
+ NK/NK-like T cells, because neutralization of these
interleukins resulted in abrogation or a strong reduction of IFN-c
production, respectively. (3) Recombinant IL-18 was able to
enhance the induction of IFN-c in CD56
+ in response to
supernatants of Salmonella infected MQ1. However, neutralization
of IL-18 did not significantly reduce the IFN-c production. These
results support that IL-23 and IL-1b, but not IL-18, in the
Figure 7. GM-CSF and IFN-c prime monocytes for enhanced IL-23 production. 1 ?10
5 CD14
+ monocytes were prestimulated with GM-CSF
(A) or IFN-c (B) for 16 hours in concentrations indicated. Subsequently cells were stimulated with heat killed Salmonella (moi=10) or left
unstimulated for 24 hours. Supernatants were taken and IL-23 production was measured by ELISA. Data are means6SD of triplicates in one
representative experiment of five.
doi:10.1371/journal.pone.0008396.g007
Figure 8. IFN-c in supernatants of IL-23 plus IL-1b stimulated CD56
+ cells primes monocytes for IL-12p70 production in response to
LPS. 1 ?10
5 CD14
+ monocytes were stimulated with 100 ng/ml LPS in combination with 2.5 ng/ml IFN-c, supernatants of unstimulated CD56
+ cells,
supernatants of IL-23 plus IL-1b stimulated CD56
+ cells, or medium alone for 24 hours (A). 1 ?10
5 CD14
+ monocytes were stimulated with 100 ng/ml
LPS in combination supernatants of IL-23 plus IL-1b stimulated CD56+ cells, plus or minus 2 mg/ml anti-IFN-c for 24 hours (B). Supernatants were
taken and IL-12p70 production was measured by ELISA. Data are means6SD of triplicates from one representative experiment of three.
doi:10.1371/journal.pone.0008396.g008
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induction of IFN-c in CD56
+ cells. Moreover, in CD56
+ cells
stimulated with IL-23 no synergy is seen with IL-18 when
concentrations lower than 20 ng/ml IL-18 are used [8], indicating
that the IL-18 concentration induced by Salmonella (which was
,1–4 ng/ml) may be too low to synergize with IL-23 in inducing
IFN-c. In addition, Salmonella infection is known to induce TNF
production in macrophages and TNF has been reported to
enhance IFN-c production [17,23]. Therefore, in our experi-
ments, TNF in the supernatants of infected MQ1 may also
enhance IFN-c production. However, we did not determine the
role of TNF in this respect. (4) IFN-c and GM-CSF both
enhanced IL-23 production in monocytes in response to various
stimulations. (5) Moreover, both cytokines could be induced by IL-
23, in combination with IL-18 or IL-1b, in CD56
+ cells.
Depending on the concentrations used, IL-23 plus IL-18 or IL-
1b induced more than 200 pg/ml GM-CSF, a concentration
which we have shown to be sufficient to prime CD14
+ monocytes
for enhanced IL-23 production.
Together these observations confirm the presence of a positive
feedback loop in which IL-23 can enhance its own expression via
the induction of IFN-c and GM-CSF. In line with our
observations, IFN-c was recently reported to enhance Francisella
tularensis induced IL-23 in human monocytes [24]. IFN-c allows
for the transcription of IL-12p35 in response to LPS [25] and for
the induction of IL-12 in response to a PAMP an additional
stimulus such as IFN-c is needed [5]. Herein we show that IL-23
together with IL-1b present in supernatants of Salmonella infected
MQ1 can provide this costimulus by the induction of IFN-c in NK-
like T cells, thereby allowing subsequent IL-12p70 production in
response to Salmonella and the initiation of a Th1 response. In
contrast, in human DCs IFN-c can inhibit IL-23p19 mRNA
transcription [26], emphasizing the complexity of the regulation of
this cytokine.
In this study we report on a positive feedback of IL-23
production, but negative feedback mechanisms may exist as well.
For instance, IL-4 and IL-10 are both reported to inhibit the
induction of IL-23 and may serve as a negative feedback [27]. IL-4
may be important in balancing IL-23 and IL-12 production as IL-
4 can enhance IL-12p70 production [28–30]. It would be
interesting to explore the effects of these and other potential
negative regulators of IL-23.
To reach the conclusion on a positive feedback loop in which
IL-23 enhances its own expression via the induction of IFN-c and
GM-CSF, the following pitfalls of this study need to be considered.
Firstly, in supernatants of MQ1 infected with live Salmonella,w e
neutralized IL-23 using an antibody which is able to neutralize IL-
12p70 as well. Though we did not detect IL-12p70 and IL-12p35
mRNA expression was not induced by infection with Salmonella,
one should bear in mind that the detection limit of the IL-12p70
ELISA used was 3 pg/ml and that we can not exclude that the
effect observed after neutralizing the IL-23 is due to the
neutralization of small, undetectable amounts of IL-12p70.
Secondly, the concentrations of the TLR agonists used may
exceed physiological relevant conditions. For example, the
concentrations of Salmonella LPS added to the cells used in this
study are likely to differ from LPS concentration when MQ1 are
being infected with live Salmonella. During sepsis 5–10 pg/ml LPS
can be detected in the blood [31]. Thirdly, between donors we
observed interindividual differences in cytokine production in
response to the stimulations used. This may reflect differences in
responsiveness to stimulation and differences in capacity to
produce cytokines between cells obtained from different donors.
We observed for example remarkable interindividual differences in
the subset of IFN-c producing CD56
+ cells in response to IL-23 in
combination with IL-1b or IL-18.
In addition to the elucidation of the positive feed-back loop of
IL-23 expression we observed a synergy between LPS (TLR4) and
flagellin (TLR5) and between LPS and CL075 (TLR8/7) with
respect to the induction of IL-23 production in monocytes and
MQ1. During an infection, synergy between TLRs is likely of
importance because pathogens express multiple TLR agonists.
LPS and flagellin for instance, which in synergy induce large
quantities of IL-23 in MQ1, are both expressed by Salmonella.
Synergy between LPS (TLR4) and R848, another TLR8/7
agonist, has been observed in the induction of IL-12 and IL-23
in human DCs [32]. Both TLR8 and TLR4 are implicated in the
resistance against M. tuberculosis [33,34], suggesting the synergy we
observed between the TLR4 and the TLR8/7 agonists may be
relevant in mycobacterial infections.
In conclusion, we have shown that various TLR agonists and
infection with Salmonella can induce IL-23, IL-18 and IL-1b, but
not IL-12, production in monocytes and MQ1. Furthermore, our
findings indicate that a positive feedback loop exists in which IL-23
can enhance its own production via the induction of IFN-c and
GM-CSF, which both prime monocytes for enhanced IL-23
production. Last, IL-23, in combination with IL-1b, could prime
monocytes to produce IL-12p70 in response to LPS, via the
activation of CD56
+ cells, thereby amplifying the type-1 cytokine
pathway to IFN-c production.
IL-23 plus IL1b induced IFN-c production in CD56
+ cells,
which consist of CD56
+/CD3
2 NK cells and CD56
+CD3
+ NK-
like T cells. In half of the donors IFN-c production was observed
in both NK cells and NK-like T cells, whereas in the other half
IFN-c production was observed only in the NK cells. Possible
explanations for these interindividual differences may be previous
(recent) exposure to different pathogens or genetic differences
between donors; these may be elucidated when individual donors
are assayed at regular intervals over a longer time period to
determine whether or not the individual cytokine production
profiles are constant.
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